首页 / 国际专利分类库 / 化学;冶金 / C07有机化学 / 无环或碳环化合物 / 含有氮原子之间以单键相连的链的化合物,例如肼、三氮烷
序号 专利名 申请号 申请日 公开(公告)号 公开(公告)日 发明人
41 2,4-Dihalo-5-substituted phenylhydrazines and their production and use. EP86201148 1983-09-28 EP0206435A2 1986-12-30 NAGANO EIKI; TAKEMOTO ICHIKI; FUKUSHIMA MASAYUKI; YOSHIDA RYO; MATSUMOTO HIROSHI C O SUMITOMO
A compound of the formula wherein X is a chlorine atom or a bromine atom and B is a nitro group or a hydroxyl group, which are intermediates useful in the production of certain 2-substituted phenyl-4,5,6,7-tetrahydro-2H-indazoles having herbicidal activity.
42 Indole-2-alkanoic acids and their use as prostaglandin antagonists EP85304468 1985-06-24 EP0166591A3 1986-06-25 Guindon, Yvan; Gillard, John W.; Yoakim, Christiane; Jones, Thomas R.; Fortin, Rejean

Compounds of the formula I

where

  • R1 is H or alkyl of 1 to 6 carbons or R1 and R8 taken together form a group (CH2)v wherein v is 1 to 7;
  • R2 is

    where
  • each R8 is independently H, OH, C1 to C4-O-alkyl or alkyl of 1 to 4 carbons; or an R1 and an R8 taken together form a group (CH2)v wherein v is 1 to 7,
  • R9 is COOR1; CH2OH; CHO; tetrazole; NHSO2R10 wherein R10 is OH, alkyl or alkoxy of 1 to 6 carbons, perhaloalkyl of 1 to 6 carbons, phenyl or phenyl substituted by alkyl or alkoxy groups of 1 to 3 carbons, halogen, hydroxy, COOH, CN, formyl or acyl of 1 to 6 carbons; CONHSO2R10; hydroxymethylketone; CN; or CON(R8)2;
  • X is O; S; SO; S02; NR11 wherein R11 is H, alkyl of 1 to 6 carbons, acyl of 1 to 6 carbons, CN; CR1R8;

    or the unit wherein the dotted line represents an optical triple bond and in which the R1 and R8 substituents are absent when a triple bond is present;
  • r and q are each independently 0 to 5 and p is 0 or 1 provided that the total of p, q and r is 2 to 6;
  • R3 is H, alkyl of 1 to 6 carbons; phenyl or phenyl substituted by R4; or C1 to C4 alkylphenyl or C1 to C4 alkylphenyl in which the phenyl is substituted by R4;
  • R4, R5, R6 and R7 are each independently selected from:
    • (1) hydrogen;
    • (2) alkyl having 1 to 6 carbon atoms;
    • (3) alkenyl having 2 to 6 carbon atoms;
    • (4) -(CH2)nM

      wherein n is 0 to 3 and M is
      • a) OR12;
      • b) halogen;
      • c) CF3;
      • d) SR12;
      • e) phenyl or substituted phenyl wherein substituted phenyl is as defined below in the definition of R12;
      • f) COOR13;
      • g)
      • h) tetrazole;
      • i) wherein R15 is C1 to C6 alkyl, benzyl or phenyl;
      • j) -NR13R13;
      • k) -NHSO2R16 wherein R16 is C1 to C6 alkyl, phenyl, or CF3;
      • I)
      • m) -SOR12;
      • n) -CON13R13;
      • o) -SO2NR13R13;
      • p) -SO2R12;
      • q) N02;
      • r)
      • s)
      • t)
      • u) CN;
  • each R12 independently is H; C1 to C6 alkyl; benzyl; phenyl or substituted phenyl wherein the substituents are C1 to C3 alkyl, halogen, CN, CF3, COOR13, CH2COOR13, C1 to C3 alkoxy, or C1 to C4 perfluoroalkyl;
  • each R13 is independently H, phenyl or C1 to C6 alkyl; and,
  • each R14 independently is H, (CH2)nCOOR13 wherein n is 0 to 4, C1 to C6 alkyl, CF3, phenyl, or substituted phenyl wherein substituted phenyl is as defined above in the definition of R12;


and their pharmaceutically acceptable salts are useful as prostaglandin antagonists and are made into pharmaceutical compositions. Certain of the compounds are novel.

43 Indole-2-alkanoic acids and their use as prostaglandin antagonists EP85304468.3 1985-06-24 EP0166591A2 1986-01-02 Guindon, Yvan; Gillard, John W.; Yoakim, Christiane; Jones, Thomas R.; Fortin, Rejean

Compounds of the formula I

where

  • R1 is H or alkyl of 1 to 6 carbons or R1 and R8 taken together form a group (CH2)v wherein v is 1 to 7;
  • R2 is

    where
  • each R8 is independently H, OH, C1 to C4-O-alkyl or alkyl of 1 to 4 carbons; or an R1 and an R8 taken together form a group (CH2)v wherein v is 1 to 7,
  • R9 is COOR1; CH2OH; CHO; tetrazole; NHSO2R10 wherein R10 is OH, alkyl or alkoxy of 1 to 6 carbons, perhaloalkyl of 1 to 6 carbons, phenyl or phenyl substituted by alkyl or alkoxy groups of 1 to 3 carbons, halogen, hydroxy, COOH, CN, formyl or acyl of 1 to 6 carbons; CONHSO2R10; hydroxymethylketone; CN; or CON(R8)2;
  • X is O; S; SO; S02; NR11 wherein R11 is H, alkyl of 1 to 6 carbons, acyl of 1 to 6 carbons, CN; CR1R8;

    or the unit wherein the dotted line represents an optical triple bond and in which the R1 and R8 substituents are absent when a triple bond is present;
  • r and q are each independently 0 to 5 and p is 0 or 1 provided that the total of p, q and r is 2 to 6;
  • R3 is H, alkyl of 1 to 6 carbons; phenyl or phenyl substituted by R4; or C1 to C4 alkylphenyl or C1 to C4 alkylphenyl in which the phenyl is substituted by R4;
  • R4, R5, R6 and R7 are each independently selected from:
    • (1) hydrogen;
    • (2) alkyl having 1 to 6 carbon atoms;
    • (3) alkenyl having 2 to 6 carbon atoms;
    • (4) -(CH2)nM

      wherein n is 0 to 3 and M is
      • a) OR12;
      • b) halogen;
      • c) CF3;
      • d) SR12;
      • e) phenyl or substituted phenyl wherein substituted phenyl is as defined below in the definition of R12;
      • f) COOR13;
      • g)
      • h) tetrazole;
      • i) wherein R15 is C1 to C6 alkyl, benzyl or phenyl;
      • j) -NR13R13;
      • k) -NHSO2R16 wherein R16 is C1 to C6 alkyl, phenyl, or CF3;
      • I)
      • m) -SOR12;
      • n) -CON13R13;
      • o) -SO2NR13R13;
      • p) -SO2R12;
      • q) N02;
      • r)
      • s)
      • t)
      • u) CN;
  • each R12 independently is H; C1 to C6 alkyl; benzyl; phenyl or substituted phenyl wherein the substituents are C1 to C3 alkyl, halogen, CN, CF3, COOR13, CH2COOR13, C1 to C3 alkoxy, or C1 to C4 perfluoroalkyl;
  • each R13 is independently H, phenyl or C1 to C6 alkyl; and,
  • each R14 independently is H, (CH2)nCOOR13 wherein n is 0 to 4, C1 to C6 alkyl, CF3, phenyl, or substituted phenyl wherein substituted phenyl is as defined above in the definition of R12;


and their pharmaceutically acceptable salts are useful as prostaglandin antagonists and are made into pharmaceutical compositions. Certain of the compounds are novel.

44 N-PHENYLPYRAZOLE DERIVATIVES EP82902079.1 1982-07-15 EP0084033B1 1985-10-02 HATTON, Leslie Roy; PARNELL, Edgar William; ROBERTS, David Alan
N-phenylpyrazole derivatives of formula: <IMAGE> (wherein R<12> represents a chlorine atom, R<13> represents a hydrogen, fluorine or chlorine atom, R<14> represents a hydrogen or fluorine atom and R<15> represents a hydrogen, fluorine or chlorine atom, with the proviso that when R<14> represents a fluorine atom, R<15> represents a fluorine or chlorine atom, or R<12>, R<13> and R<15> each represent a fluorine atom and R<14> represents a hydrogen or fluorine atom) possess useful herbicidal properties. Herbicidal compositions, method for controlling the growth of weeds and processes for the preparation of the N-phenylpyrazole derivatives are described, as well as intermediates of formula:
45 Silver halide photographic light-sensitive material EP84115660.7 1984-12-17 EP0147765A2 1985-07-10 Kobayashi, Hidetoshi c/o Fuji Photo Film Co., Ltd.; Mihayashi, Keiji c/o Fuji Photo Film Co., Ltd.

A silver halide photographic light-sensitive material comprising a support and at least one silver halide emulsion layer wherein the silver halide photographic light-sensitive material contains at least one compound represented by the following general formula (I): wherein COUP represents a coupler residue capable of undergoing a coupling reaction with an oxidation product of an aromatic primary amine developing agent; TIME represents a timing group which is released from COUP the coupling reaction and subsequently releases represents a group capable of being released from COUP by the coupling reaction when n is 0, or a group capable of being released from TIME after TIME which has been released from COUP when n is 1, AD being adsorptive to silver halide particles; R represents an alkyl group, an aryl group or a heterocyclic group; R' and R", which may be the same or different, each represents a hydrogen atom or a substitutent; and -NHNHCOR may be directly connected to AD when AD is combined with the benzene ring to form a condensed ring system.

The'silver halide photographic light-sensitive material containing the compound represented by general formula (I) is improved in stability during storage and has a high sensitivity.

46 Herbicidal Fluorophenoxyphenoxypropionates, derivatives thereof and related compounds EP84306000 1984-08-31 EP0138359A3 1985-06-12 Rogers, Richard B.; Genwick, B. Clifford III

Novel fluorophenoxyphenoxypropionates and derivatives thereof and compounds related thereto possess herbicidal activity selectively in the presence of broadleaf crops. Preemergent and postemergent applications are contemplated.

The compounds are of the formula wherein

  • X represents -F, -Cl, -Br, -I, -CF3, -OCF3, -CF2CI, -CF2H or-CF2CCl2H; and
  • Z represents an organic moiety, the moiety containing N, O or S atoms, a metallic cation, an ammonium cation or an organic amine cation and is, or can be hydrolyzed and/or oxidized in plants or soil to, a carboxyl moiety that is in undissociated and/or dissociated form.
  • Preferably Z ist or an agriculturally acceptable salt, amide or ester thereof.
  • Also provided are novel intermediates of the formula wherein
  • Y is OH, NH2 or N2⊕ BF4⊖, as well as herbicidal compositions and a method of controlling weeds by applying to them one or more of the active compounds of the invention.

47 Peptides, processes for their preparation and pharmaceutical compositions containing them EP80106143.3 1980-10-09 EP0027260B1 1985-03-13 Kitaura, Yoshihiko; Nakaguchi, Osamu; Hemmi, Keiji; Aratani, Matsuhiko; Takeno, Hidekazu; Okada, Satoshi; Tanaka, Hirokazu; Hashimoto, Masashi
48 Benzothiopyrano(4,3,2,-cd)indazoles, their pharmaceutical compositions and methods for their production EP83308029.4 1983-12-29 EP0114002A2 1984-07-25 Elslager, Edward F.; Werbel, Leslie M.; Ortwine, Daniel F.; Worth, Donald F.; Showalter, Howard D.H.

Chemical compounds are provided that are novel substituted benzothiopyrano[4,3,2-cd]indazoles, as well as methods for their production, pharmaceutical compositions comprising the compounds, and methods of treatment using the compounds in dosage form. Compounds of the invention have pharmacological properties and are useful antibacterial agents, antifungal agents, and antitumor agents.

49 Verfahren zur Herstellung von 1-(2-(2,4-Dichlorphenyl)pentyl)-1H-1,2,4-triazol und neue Hydrazon- oder Hydrazinderivate EP83810259.8 1983-06-13 EP0097617A1 1984-01-04 Wetter, Hansjürg, Dr.; Baumeister, Peter; Radimerski, Paul, Dr.; Martin, Pierre, Dr.

1-[2-(2,4-Dichlorphenyl)pentyl]-1H-7,2,4-triazol kann nach einem neuen einfachen und wirtschaftlichen Verfahren in isomerenfreier Form hergestellt werden, indem man 2-(2,4-Dichlorphenyl)-valero-nitril in Gegenwart von Wasserstoff, einer Säure und eines Hydrierungskatalysators mit einer Verbindung H2N-NH-R zu einer Verbindung der Formel umsetzt, die Verbindung (III) katalytisch zu einer Verbindung hydriert, Verbindungen (IV) mit R ungleich H hydrolysiert und die Verbindungen (IV) mit R=H oder Salze davon mit Formamid und/oder [3-(Dimethylamino)-2-azaprop-2-en-1-yliden]-dimethylammoniumchlorid in das 1-[2-(2,4-Dichlorphenyl)pentyl]-1H-1,2,4-triazol überführt, oder Verbindungen (IV) mit R = -COR' mit wässriger Ameisensäure in die entsprechenden N,N'-Bisformylderivate überführt und diese mit Formamid, gegebenenfalls in Gegenwart von NH3, zum 1-[2-(2,4-Dichlorphenyl)pentyl)-1H-1,2,4-triazol umsetzt. Dabei ist R Wasserstoff, -CHO, -COR', -COOR' oder -CONH2 und R' bedeutet C1-4-Alkyl, Benzyl oder Phenyl. Das 1-[2-(2,4-Dichlorphenyl)-pentyl)-1H-1,2,4-triazol besitzt funizide Wirkung und kann zur Bekämpfung phytopathogener Pilze verwendet werden.

50 New peptide, process for its preparation and pharmaceutical composition containing it EP81108796.4 1981-10-23 EP0050856A2 1982-05-05 Kitaura, Yoshihiko; Nakaguchi, Osamu; Hemmi, Keiji; Aratani, Matsuhiko; Takeno, Hidekazu; Okada, Satoshi; Tanaka, Hirokazu; Hashimoto, Masashi; Kuroda, Yoshio; Iguchi, Eiko; Kohsaka, Masanobu; Aoki, Hatsuo; Imanaka, Hiroshi

A compound of the formula or its pharmaceutically acceptable salt: where, in one example. R' is n-octanoyl, n is the integer O, R2 is benzyl, R3 is 1-carboxyethylammo, R4 is hydrogen and R5 is hydrogen and processes for their preparation and also a pharmaceutically composition comprising, as an effective ingredient, the above compound in association with pharmaceutically acceptable carriers.

51 N-phenylpyrazole derivatives EP81300767 1981-02-24 EP0034945A3 1982-04-21 Hatton, Leslie Roy; Parnell, Edgar William; Roberts, David Alan

N-Phenylpyrazole derivatives of the formula:- (wherein each of R5 and R6 represents a C1-C4 alkyl or alkoxy radical, a trifluoromethyl, trifluoromethoxy, nitro, cyano or primary amino radical, or a fluorine, chlorine or bromine atom, each of R', R' and R9 represents a hydrogen atom, a C1-C4 alkyl or alkoxy radical, a trifluoromethyl, trifluoromethoxy, nitro, cyano or primary amino radical or a fluorine, chlorine or bromine atom, or R5, R7, R' and R9 each represents a hydrogen atom and R6 represents a trifluoromethoxy or trifluoromethyl radical, and R10 represents a cyano radical or substituted carbamoyl radical -CONHR", wherein R" represents a methyl or ethyl radical) have been found to possess useful herbicidal properties. All such N-phenylpyrazole derivatives with the exception of 5-amino-4-cyano-1-(2,4-dichlorophenyl)pyrazole and 5-amino-4-cyano-1- (4-chloro-2-methylphenyl)pyrazole are new compounds. Herbicidal compositions containing such N-phenylpyrazole derivatives are described and also processes for the prepararation of the new compounds.

52 N-phenylpyrazole derivatives EP81300767.1 1981-02-24 EP0034945A2 1981-09-02 Hatton, Leslie Roy; Parnell, Edgar William; Roberts, David Alan

N-Phenylpyrazole derivatives of the formula:- (wherein each of R5 and R6 represents a C1-C4 alkyl or alkoxy radical, a trifluoromethyl, trifluoromethoxy, nitro, cyano or primary amino radical, or a fluorine, chlorine or bromine atom, each of R', R' and R9 represents a hydrogen atom, a C1-C4 alkyl or alkoxy radical, a trifluoromethyl, trifluoromethoxy, nitro, cyano or primary amino radical or a fluorine, chlorine or bromine atom, or R5, R7, R' and R9 each represents a hydrogen atom and R6 represents a trifluoromethoxy or trifluoromethyl radical, and R10 represents a cyano radical or substituted carbamoyl radical -CONHR", wherein R" represents a methyl or ethyl radical) have been found to possess useful herbicidal properties. All such N-phenylpyrazole derivatives with the exception of 5-amino-4-cyano-1-(2,4-dichlorophenyl)pyrazole and 5-amino-4-cyano-1- (4-chloro-2-methylphenyl)pyrazole are new compounds. Herbicidal compositions containing such N-phenylpyrazole derivatives are described and also processes for the prepararation of the new compounds.

53 Novel 2-substituted-3-heterocyclylindoles, their preparation and pharmaceutical compositions containing them EP79103669.2 1979-09-27 EP0010617B1 1981-08-05 Steinman, Martin; Tahbaz, Pirouz
54 Formylderivate von Hydrazinomethylpenicillinen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel EP80108188.6 1980-12-29 EP0031951A1 1981-07-15 Bolis, Goffredo; Giani, Roberto; Pifferi, Giorgio; Broccali, Giampietro, Dr.; Pinza, Mario

Formylderivate von Hydrazinomethylpenicillinen der Formel worin

  • R für einen Thienyl- oder Phenylrest steht,
  • R' Wasserstoff, einen Formylrest oder einen Alkylrest mit 1 bis 3 Kohlenstoffatomen bedeutet,
  • R" Wasserstoff oder einen Formylrest darstellt und
  • das Sternchen (*) ein Asymmetriezentrum des Moleküles darstellt, mit der weiteren Maßgabe, daß

    mindestens eines von R' und R" einen Formylrest darstellt,


in Form der getrennten Epimere oder von Mischungen derselben sowie ihre Salze und 1-(Äthoxycarbonyloxy)-äthyl- und Pivaloyloxymethylester, sowie ein. Verfahren zur Herstellung dieser Verbindungen.

Diese Verbindungen können in Arzneimitteln auf dem Gebiet der Therapie, insbesondere als antibakterielle beziehungsweise baktericide Mittel verwendet werden.

55 2-Hydroxyoxanilic acid derivatives and salts, their preparation and pharmaceutical compositions containing them EP80304303.3 1980-11-28 EP0030436A1 1981-06-17 Murase, Kiyoshi; Mase, Toshiyasu; Arima, Hideki; Tomioka, Kenichi; Numasaki, Yoso Nishiageo

2-hydroxyoxanilic acid derivatives shown by the following formula and salts thereof possess an immunoregulatory action and can be useful as antiallergic agents, antiasthmatics, antirheumatics, carcinostatic agents, therapeutic agents for autoimmune disease, and suppressants of rejection in tissue transplants and skin grafts. They can be made from the corresponding aminophenols and oxalylic acids.

56 Peptides, processes for their preparation and pharmaceutical compositions containing them EP80106143.3 1980-10-09 EP0027260A2 1981-04-22 Kitaura, Yoshihiko; Nakaguchi, Osamu; Hemmi, Keiji; Aratani, Matsuhiko; Takeno, Hidekazu; Okada, Satoshi; Tanaka, Hirokazu; Hashimoto, Masashi

A compound of the formula or its pharmaceutically acceptable salt:

  • wherein R1 is hydrogen or acyl;
  • R2 is carboxy or protected carboxy or a group of the formula:
    • -COHN-R2 wherein R2a is carboxy(lower)alkyl or protected carboxy(lower)alkyl;
  • R3 is carboxy, protected carboxy, lower alkyl, hydroxyphenyl, carbamoyl ora graup oftheformula: R3a-CH-R3b wherein R3a is hydrogen, amino, protected amino or a cylamino, R3b is carboxy or protected carboxy;
  • RPis carboxy, protected carboxy, carbamoyl, carboxy(lower)alkyl or protected carboxy(lower)alkyl; ℓ isaninteger0or2, m is an integer 0 to 3 and n is an integer 0 to 1, with certain provisions, and pharmaceutically acceptable salts thereof and process for their preparation, and also a pharmaceutical composition comprising, as an effective ingredient, the above compound in association with a pharmaceutically acceptable, substantially nontoxic carrier or excipient.

57 Pharmaceutical compositions containing 3-Amino-pyrazoline derivatives EP80104029.6 1980-07-11 EP0022578A1 1981-01-21 Challand, Stanley Richard; Copp, Frederick Charles; Denyer, Clive Vincent; Eakins, Kenneth Ernest; Walker, John Michael Graham; Whittaker, Norman; Caldwell, Albert Gordon

Heterocyclic compounds of formula (I) and their acid addition salts exhibit anti-inflammatory activity and when administered topically do not provide the side-effects associated with their systemic administration. The novel compounds of formula (I) may be prepared by methods known in the art and may be topically administered as the compound alone or in a suitable pharmaceutical formulation.

58 Novel 2-substituted-3-heterocyclylindoles, their preparation and pharmaceutical compositions containing them EP79103669.2 1979-09-27 EP0010617A1 1980-05-14 Steinman, Martin; Tahbaz, Pirouz

2-Substituted-3-heterocyclyl-indoles of the formula wherein X is a hydrogen or halogen atom,

  • n is 1, or 3 (when X is halogen atom),
  • Q is an oxygen atom or the group (H, OH),
  • Z is a hydrogen atom or, provided that Q is an oxygen atom, Z can also be the group OR, wherein R is a hydrogen atom or a lower alkyl or loweralkoxy-loweralkyl group,
  • m is 1 or 2 when Z is a hydrogen atom and m is O when
  • Z is the group OR,
  • and Het is a heterocyclic radical selected from pyridyl, lower-alkyl-substituted pyridyl, pyrimidinyl, pyridazinyl, pyrazinyl, pyrazolyl, imidazolyl, thiazolyl, isothiazolyl, thienyl, furanyl, pyrrolyl, oxazolyl and isoxazolyl, have immuno-suppressant activity and can be used for example in the treatment of rheumatoid arthritis.

Their preparation and pharmaceutical compositions containing them are also described.

59 Photographic element containing substituted 1-phenyl-3-pyrazolidinone electron transfer agent EP79200530.8 1979-09-24 EP0009837A2 1980-04-16 McCreary, Michael Dale; Farley, William Charles; Erickson, Wayne Francis

A photographic element is provided which contains a substituted 1-phenyl-3-pyrazolidinone electron transfer agent. Such electron transfer agent has the following formula: wherein:

  • R is hydrogen or a hydrolyzable moiety;
  • R1 is hydrogen or a hydroxy group;
  • R2, R3 and R4 each represent hydrogen, hydroxy, an alkyl group of 1 to 3 carbon atoms, an alkoxy group of 1 to 3 carbon atoms, a phenyl group, -NHSO2R5, -O(CH2)nOR6, -(CH2)nOR6, -O(CH2)nC6H5, -(CH2)nR7, or -O(CH2)nR7;
  • R5 is hydrogen or an alkyl group of 1 to 3 carbon atoms;
  • R6 is hydrogen or a methyl group;
  • R7 is NHSO2R5 or SO2NHR5; and
  • n is a positive integer of 1 to 2;


with the proviso that at least one of R2, R3 and R4 is a substituent other than hydrogen.

60 Heterocyclic-substituted anilide derivatives, a process for their preparation, herbicidal compositions containing them and a method of controlling undesired plant growth using them EP79200001 1979-01-02 EP0003619A3 1979-09-05 Pilgram, Kurt Hans Gerhard

Novel compounds are provided of the general formula wherein RI represents a hydrogen atom, an optionally substituted cycloalkyl group having 3 to 5 ring carbon atoms and a total of 3 to 6 carbon atoms, or an alkyl group having 1 to 4 carbon atoms or an alkenyl group having 2 or 3 carbon atoms which groups may be unsubstituted or substituted by one or more fluorine, chlorine and/or bromine atoms; R2 represents a fluorine, chlorine or bromine atom, a trifluoromethyl, nitro or cyano group, or an alkyl, alkoxy or alkylthio group having from 1 to 6 carbon atoms; and A represents various optionally-substituted 5-membered heterocycles containing up to 3 nitrogen atoms and also in some cases an oxygen atom. These compounds have herbicidal activity.

QQ群二维码
意见反馈